Psomagen Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 88

Employees

  • Stock Symbol
  • 950200

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $1.93
  • (As of Friday Closing)

Psomagen General Information

Description

Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Contact Information

Formerly Known As
Macrogen Corp.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1330 Piccard Drive
  • Suite 103
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 1330 Piccard Drive
  • Suite 103
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Psomagen Stock Performance

As of 20-Nov-2026, Psomagen’s stock price is $1.93. Its current market cap is $37.2M with 19.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.93 $1.95 $1.54 - $3.37 $37.2M 19.2M 376K -$0.06

Psomagen Financials Summary

As of 31-Mar-2026, Psomagen has a trailing 12-month revenue of $42.8M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 44,676 52,819 49,150 69,265
Revenue 42,774 41,593 32,001 24,685
EBITDA 1,547 1,210 (720) (442)
Net Income (1,134) (2,096) (4,117) (3,280)
Total Assets 35,292 34,571 37,636 34,607
Total Debt 9,915 9,164 7,679 3,872
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Psomagen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Psomagen‘s full profile, request access.

Request a free trial

Psomagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-en
Other Pharmaceuticals and Biotechnology
Rockville, MD
88 As of 2025

Beijing, China
 

Bellevue, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Psomagen Competitors (5)

One of Psomagen’s 5 competitors is Novogene, a Formerly PE-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novogene Formerly PE-Backed Beijing, China
Viome Life Sciences Venture Capital-Backed Bellevue, WA
Agendia Venture Capital-Backed Irvine, CA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Hummingbird Bioscience Venture Capital-Backed Singapore, Singapore
You’re viewing 5 of 5 competitors. Get the full list »

Psomagen Patents

Psomagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021206480-A1 Composition and method for an antibiotic-inducing imbalance in microbiota Inactive 08-Apr-2020
US-11781132-B2 Dna extraction method using microwave for next generation sequencing and use thereof Active 05-Nov-2019
US-20210130812-A1 Dna extraction method using microwave for next generation sequencing and use thereof Active 05-Nov-2019
JP-2022527802-A By-products of the microbial flora and their use Pending 29-Mar-2019
AU-2020256101-A1 Microbiome byproducts and uses thereof Inactive 29-Mar-2019 G16B40/20
To view Psomagen’s complete patent history, request access »

Psomagen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Psomagen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Psomagen‘s full profile, request access.

Request a free trial

Psomagen Investments (6)

Psomagen’s most recent deal was a Later Stage VC with ImmuneMed. The deal was made on 02-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ImmuneMed 02-Nov-2021 Later Stage VC Diagnostic Equipment
Ubiome (patents and data in San Francisco, California) 02-Jan-2020 Corporate Asset Purchase Buildings and Property
Seonglim (Daebong Building in Seoul, South Korea) 28-Jun-2019 Corporate Asset Purchase Buildings and Property
Microba 01-Jun-2019 Early Stage VC Laboratory Services (Healthcare)
3billion 01-Jan-2018 Early Stage VC Diagnostic Equipment
You’re viewing 5 of 6 investments. Get the full list »

Psomagen Exits (3)

Psomagen’s most recent exit was on 01-Jun-2019 from Microba. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Microba 01-Jun-2019 Completed
3billion 01-Jan-2018 Completed
  • 6 buyers
BioMicro Systems 17-Jan-2001 Early Stage VC Completed
  • 2 buyers
To view Psomagen’s complete exits history, request access »

Psomagen FAQs

  • When was Psomagen founded?

    Psomagen was founded in 1997.

  • Where is Psomagen headquartered?

    Psomagen is headquartered in Rockville, MD.

  • What is the size of Psomagen?

    Psomagen has 88 total employees.

  • What industry is Psomagen in?

    Psomagen’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Psomagen a private or public company?

    Psomagen is a Public company.

  • What is Psomagen’s stock symbol?

    The ticker symbol for Psomagen is 950200.

  • What is the current stock price of Psomagen?

    As of 20-Nov-2026 the stock price of Psomagen is $1.93.

  • What is the current market cap of Psomagen?

    The current market capitalization of Psomagen is $37.2M.

  • What is Psomagen’s current revenue?

    The trailing twelve month revenue for Psomagen is $42.8M.

  • Who are Psomagen’s competitors?

    Novogene, Viome Life Sciences, Agendia, Genetix Biotherapeutics, and Hummingbird Bioscience are competitors of Psomagen.

  • What is Psomagen’s annual earnings per share (EPS)?

    Psomagen’s EPS for 12 months was -$0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process